# Amgen Inc. (AMGN) — Q2-2008 Earnings Results

**Report date:** 2008-07-28 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2008

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 12.17%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +16.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's strategic direction. They emphasized the importance of innovation and maintaining a strong pipeline.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development.

> The focus remains on long-term growth despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a solid EPS beat, which likely contributed to the stock's 12.17% increase in value. Investors reacted positively to the company's performance in key areas, even without revenue figures. The management's focus on innovation and long-term growth suggests they are positioning the company well for future challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2008_